Minireview: Drug Discovery Using Receptors that Modulate Gene Expression

References

• Evans R. M. The steroid and thyroid hormone receptor superfamily. Science 1989; 240: 889–895
   Web of Science ®Google Scholar
• Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schutz G., Umesone K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M. The nuclear receptor superfamily: The second decade. Cell 1995; 83: 835–839
   PubMed Web of Science ®Google Scholar
• Beato M., Herrlich P., Schutz G. Steroid hormone receptors: Many actors in search of a plot. Cell 1995; 83: 851–857
   PubMed Web of Science ®Google Scholar
• Miyajama A., Kitamura T., Harada N., Yokata T., Arai K. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 1992; 10: 295
   PubMed Web of Science ®Google Scholar
• Darnell J. E., Jr., Kerr I. M., Stark G. R. JAK-STAT pathways and transcriptional activation in response IFNs and other extracellular signaling proteins. Science 1994; 264: 1415–1421
   PubMed Web of Science ®Google Scholar
• Ihle J. N., Witthuhn B. A., Quelle F. W., Yamamoto K., Thierfelder W. E., Kreider B., Silvennoinen O. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends in Biochemical Sciences 1994; 19: 222–227
   PubMed Web of Science ®Google Scholar
• Ihle J. N. Cytokine receptor signaling. Nature 1995; 377: 591–594
   PubMed Web of Science ®Google Scholar
• Pratt W. B. Interaction of hsp90 with steroid hormone receptors: Organizing some diverse observations and presenting the newest concepts. Mol. Cell. Endocrinol. 1995; 74: C69–C76
   Google Scholar
• Allan G. F., Leng K., Tsai S.-Y., Weigel N. L., Edwards D. P., Tsai M.-J., O'Malley B. W. Hormone and Anti-hormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 1992; 267: 19513–19520
   PubMed Web of Science ®Google Scholar
• Allan G. F., Tsai S.-Y., O'Malley B. W., Tsai M.-J. Steroid hormone receptors and in vitro transcription. BioEssays 1991; 13: 73–78
   PubMed Web of Science ®Google Scholar
• Glass C. K. Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocrinol. Rev. 1994; 15: 391–407
   PubMed Web of Science ®Google Scholar
• Naar A. M., Boutin J.-M., Lipkin S. M., Yu V. C., Holloway J M., Glass C. K., Rosenfeld M. G. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell 1991; 65: 1267–1279
   PubMed Web of Science ®Google Scholar
• Yu V. C., Delseret C., Anderson B., Hollowly J. M., Devary O. V., Naar A. M., Kim S. Y., Boutin J. M., Glass C K., Rosenfeld M. G. RXRb: A coregulator that enhances binding of retinoic acid, thyroid hormone and vitamin D3 receptors to their cognate response elements. Cell 1991; 67: 1251–1266
   PubMed Web of Science ®Google Scholar
• Mangelsdorf D. J., Umesono K., Evans R. M. The Retinoid Receptors. The Retinoids, M. B. Sporn, A. B. Roberts, D. S. Goodman. Raven Press, New York 1994; 319–349
   Google Scholar
• Dawson M. I., Hobbs P. D., Stein R. B., Berger T. S., Heyman R. A. Interaction of retinoids with retinoic acid nuclear receptor isoforms. Retinoids: Progress in Research and Clinical Applications, M. A. Livrea, L. Packer. Marcel Dekker, New York 1993; 205–221
   Google Scholar
• Delescluse C., Cavey M. T., Martin B., Bernard B. A., Reichert U., Maignan J., Darmon M., Shroot B. Selective high affinity retinoic receptor α or β-γ ligands. Mol. Pharm. 1991; 40: 556–562
   PubMed Web of Science ®Google Scholar
• Esgleyes-Ribot T., Chandraratna R. A. S., Lew-Kaya D., Sefton J., Duvic M. J. Response of psoriasis to a new topical retinoid, AGN190168. J. Am. Acad. Dermatol. 1994; 30: 581–590
   PubMed Web of Science ®Google Scholar
• Wakeling A. E., Valcaccia B., Newboult E., Green L. R. Non-steroidal anti-estrogens-receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells. J. Steroid Biochem. 1984; 20: 111–120
   PubMedGoogle Scholar
• Tzukerman M. T., Esty A., Santiso-Mere D., Danielian P., Parker M. G., Stein R. B., Pike J. W., McDonnell D. P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 1994; 8: 21–30
   PubMed Web of Science ®Google Scholar
• Miner J. N., Diamond M. I., Yamamoto K. R. Joints in the regulatory lattice: composite regulation by steroid receptor-AP-1 complexes. Cell Growth and Diff. 1991; 2: 525–530
   PubMedGoogle Scholar
• Jonat C., Rahmsdorf H. J., Park K.-K., Cato A. C. B., Gebel S., Ponta H., Herrlich P. Anti-tumor promotion and antiinflammation: Down modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990; 62: 1189–1204
   PubMed Web of Science ®Google Scholar
• Imai E., Stromstedt P.-E., Quinn Carlstedt-Duke J., Gustafsson J.-A., Granner D. Characterization of a complex glucocorticoid response unit in the PEPCK gene. Mol. Cell. Biol. 1990; 10: 4712–4719
   PubMed Web of Science ®Google Scholar
• Heck S., Kullman M., Gast A., Ponta H., Rahmsdorf H. J., Herrlich P., Cato A. C. B. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 1994; 14: 452–460
   Google Scholar
• Greenland A. C., Farrar M. A., Viviano B. L., Schreiber R. D. Ligand-induced IFNγ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 1994; 13: 1591–1600
   PubMed Web of Science ®Google Scholar
• Shuai K., Schindler C., Prezioso V. R., Darnell J. E. Activation of transcription by IFNγ: Tyrosine phosphorylation of a 91-kD DNA binding protein. Science 1992; 258: 1808–1812
   PubMed Web of Science ®Google Scholar
• Khan K. D., Shuai K., Lindwall G., Maher S. E., Darnell J. E., Bothwell A. L. M. Induction of the Ly-6A/E gene by interferon α/β and γ requires a DNA element to which a tyrosine-phosphorylated 91-kDa protein binds. Proc. Natl. Acad. Sci. 1993; 90: 6806–6810
   PubMed Web of Science ®Google Scholar
• Lamb P., Seidel H. M., Haslam J., Milocco L., Kessler L. V., Stein R. B., Rosen J. STAT protein complexes activated by interferon-γ and gp 130 signaling molecules differ in their sequence preferences and transcriptional induction properties. Nucl. Acids Res. 1995; 23: 3283–3289
   PubMed Web of Science ®Google Scholar
• Yuan J., Wegenka U., Lutticken C., Buschmann J., Decker T., Schindler C., Heinrich P. C., Horn F. The signaling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements. Mol. Cell. Biol. 1994; 14: 1657–1668
   PubMed Web of Science ®Google Scholar
• Seidel H. M., Milocco L. H., Lamb P., Darnell J. E., Jr., Stein R. B., Rosen J. Spacing of palindromic half sites as a determinant of selective DNA binding and transcriptional activity of signal transducers and activators of transcription. Proc. Natl. Acad. Sci. USA 1995; 92: 3041–3045
   PubMed Web of Science ®Google Scholar
• Lamb P., Haslam J., Kessler L., Seidel H. M., Stein R. B., Rosen J. Rapid Activaton of the interferon-γ signal transduction pathway by inhibitors of tyrosine phosphatases. J. Interferon Res. 1994; 14: 365–373
   PubMedGoogle Scholar
• Levitzki A., Gazit A. Tyrosine kinase inhibition: An approach to drug development. Science 1995; 267: 1782–1788
   PubMed Web of Science ®Google Scholar
• Fry D. W., Kraker A. J., McMichael A., Ambroso L. A., Nelson J. M., Leopold W. R., Connors R. W., Bridges A. J. A specific inhibitor of epidermal growth factor receptor tyrosine kinase. Science 1994; 265: 1093–1096
   PubMed Web of Science ®Google Scholar
• Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J. S., Freedman M., Cohen A., Gazit A., Levitzki A., Roifman C. M. Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor. Nature 1996; 379: 645–648
   PubMed Web of Science ®Google Scholar